drugset / Trial / NCT00095979

Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer

NCT00095979

NaSingle-groupOpen-labelTreatment

Summary

Drugs used in chemotherapy, such as ixabepilone, work in different ways to stop tumor cells from dividing so they stop growing or die. This phase II trial is studying how well ixabepilone works in treating patients with recurrent or persistent endometrial cancer.

Timeline

Start
2005-05
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ixabepilone Small molecule Intravenous